用于糖尿病视网膜病变筛查的机器学习算法的性能和局限性及其在健康管理中的应用:一项荟萃分析。

IF 2.9 4区 医学 Q3 ENGINEERING, BIOMEDICAL
Mehrsa Moannaei, Faezeh Jadidian, Tahereh Doustmohammadi, Amir Mohammad Kiapasha, Romina Bayani, Mohammadreza Rahmani, Mohammad Reza Jahanbazy, Fereshteh Sohrabivafa, Mahsa Asadi Anar, Amin Magsudy, Seyyed Kiarash Sadat Rafiei, Yaser Khakpour
{"title":"用于糖尿病视网膜病变筛查的机器学习算法的性能和局限性及其在健康管理中的应用:一项荟萃分析。","authors":"Mehrsa Moannaei, Faezeh Jadidian, Tahereh Doustmohammadi, Amir Mohammad Kiapasha, Romina Bayani, Mohammadreza Rahmani, Mohammad Reza Jahanbazy, Fereshteh Sohrabivafa, Mahsa Asadi Anar, Amin Magsudy, Seyyed Kiarash Sadat Rafiei, Yaser Khakpour","doi":"10.1186/s12938-025-01336-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In recent years, artificial intelligence and machine learning algorithms have been used more extensively to diagnose diabetic retinopathy and other diseases. Still, the effectiveness of these methods has not been thoroughly investigated. This study aimed to evaluate the performance and limitations of machine learning and deep learning algorithms in detecting diabetic retinopathy.</p><p><strong>Methods: </strong>This study was conducted based on the PRISMA checklist. We searched online databases, including PubMed, Scopus, and Google Scholar, for relevant articles up to September 30, 2023. After the title, abstract, and full-text screening, data extraction and quality assessment were done for the included studies. Finally, a meta-analysis was performed.</p><p><strong>Results: </strong>We included 76 studies with a total of 1,371,517 retinal images, of which 51 were used for meta-analysis. Our meta-analysis showed a significant sensitivity and specificity with a percentage of 90.54 (95%CI [90.42, 90.66], P < 0.001) and 78.33% (95%CI [78.21, 78.45], P < 0.001). However, the AUC (area under curvature) did not statistically differ across studies, but had a significant figure of 0.94 (95% CI [- 46.71, 48.60], P = 1).</p><p><strong>Conclusions: </strong>Although machine learning and deep learning algorithms can properly diagnose diabetic retinopathy, their discriminating capacity is limited. However, they could simplify the diagnosing process. Further studies are required to improve algorithms.</p>","PeriodicalId":8927,"journal":{"name":"BioMedical Engineering OnLine","volume":"24 1","pages":"34"},"PeriodicalIF":2.9000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11909973/pdf/","citationCount":"0","resultStr":"{\"title\":\"Performance and limitation of machine learning algorithms for diabetic retinopathy screening and its application in health management: a meta-analysis.\",\"authors\":\"Mehrsa Moannaei, Faezeh Jadidian, Tahereh Doustmohammadi, Amir Mohammad Kiapasha, Romina Bayani, Mohammadreza Rahmani, Mohammad Reza Jahanbazy, Fereshteh Sohrabivafa, Mahsa Asadi Anar, Amin Magsudy, Seyyed Kiarash Sadat Rafiei, Yaser Khakpour\",\"doi\":\"10.1186/s12938-025-01336-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>In recent years, artificial intelligence and machine learning algorithms have been used more extensively to diagnose diabetic retinopathy and other diseases. Still, the effectiveness of these methods has not been thoroughly investigated. This study aimed to evaluate the performance and limitations of machine learning and deep learning algorithms in detecting diabetic retinopathy.</p><p><strong>Methods: </strong>This study was conducted based on the PRISMA checklist. We searched online databases, including PubMed, Scopus, and Google Scholar, for relevant articles up to September 30, 2023. After the title, abstract, and full-text screening, data extraction and quality assessment were done for the included studies. Finally, a meta-analysis was performed.</p><p><strong>Results: </strong>We included 76 studies with a total of 1,371,517 retinal images, of which 51 were used for meta-analysis. Our meta-analysis showed a significant sensitivity and specificity with a percentage of 90.54 (95%CI [90.42, 90.66], P < 0.001) and 78.33% (95%CI [78.21, 78.45], P < 0.001). However, the AUC (area under curvature) did not statistically differ across studies, but had a significant figure of 0.94 (95% CI [- 46.71, 48.60], P = 1).</p><p><strong>Conclusions: </strong>Although machine learning and deep learning algorithms can properly diagnose diabetic retinopathy, their discriminating capacity is limited. However, they could simplify the diagnosing process. Further studies are required to improve algorithms.</p>\",\"PeriodicalId\":8927,\"journal\":{\"name\":\"BioMedical Engineering OnLine\",\"volume\":\"24 1\",\"pages\":\"34\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-03-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11909973/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BioMedical Engineering OnLine\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1186/s12938-025-01336-1\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BioMedical Engineering OnLine","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1186/s12938-025-01336-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

摘要

背景:近年来,人工智能和机器学习算法在糖尿病视网膜病变等疾病的诊断中得到了更广泛的应用。然而,这些方法的有效性还没有得到彻底的调查。本研究旨在评估机器学习和深度学习算法在检测糖尿病视网膜病变中的性能和局限性。方法:本研究依据PRISMA检查表进行。我们在PubMed、Scopus和谷歌Scholar等在线数据库中检索了截至2023年9月30日的相关文章。在标题、摘要和全文筛选后,对纳入的研究进行数据提取和质量评估。最后进行meta分析。结果:我们纳入了76项研究,共1,371,517张视网膜图像,其中51张用于meta分析。我们的荟萃分析显示,机器学习和深度学习算法虽然可以正确诊断糖尿病视网膜病变,但其鉴别能力有限,敏感性和特异性均显著,百分比为90.54 (95%CI[90.42, 90.66])。然而,它们可以简化诊断过程。需要进一步的研究来改进算法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Performance and limitation of machine learning algorithms for diabetic retinopathy screening and its application in health management: a meta-analysis.

Background: In recent years, artificial intelligence and machine learning algorithms have been used more extensively to diagnose diabetic retinopathy and other diseases. Still, the effectiveness of these methods has not been thoroughly investigated. This study aimed to evaluate the performance and limitations of machine learning and deep learning algorithms in detecting diabetic retinopathy.

Methods: This study was conducted based on the PRISMA checklist. We searched online databases, including PubMed, Scopus, and Google Scholar, for relevant articles up to September 30, 2023. After the title, abstract, and full-text screening, data extraction and quality assessment were done for the included studies. Finally, a meta-analysis was performed.

Results: We included 76 studies with a total of 1,371,517 retinal images, of which 51 were used for meta-analysis. Our meta-analysis showed a significant sensitivity and specificity with a percentage of 90.54 (95%CI [90.42, 90.66], P < 0.001) and 78.33% (95%CI [78.21, 78.45], P < 0.001). However, the AUC (area under curvature) did not statistically differ across studies, but had a significant figure of 0.94 (95% CI [- 46.71, 48.60], P = 1).

Conclusions: Although machine learning and deep learning algorithms can properly diagnose diabetic retinopathy, their discriminating capacity is limited. However, they could simplify the diagnosing process. Further studies are required to improve algorithms.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
BioMedical Engineering OnLine
BioMedical Engineering OnLine 工程技术-工程:生物医学
CiteScore
6.70
自引率
2.60%
发文量
79
审稿时长
1 months
期刊介绍: BioMedical Engineering OnLine is an open access, peer-reviewed journal that is dedicated to publishing research in all areas of biomedical engineering. BioMedical Engineering OnLine is aimed at readers and authors throughout the world, with an interest in using tools of the physical and data sciences and techniques in engineering to understand and solve problems in the biological and medical sciences. Topical areas include, but are not limited to: Bioinformatics- Bioinstrumentation- Biomechanics- Biomedical Devices & Instrumentation- Biomedical Signal Processing- Healthcare Information Systems- Human Dynamics- Neural Engineering- Rehabilitation Engineering- Biomaterials- Biomedical Imaging & Image Processing- BioMEMS and On-Chip Devices- Bio-Micro/Nano Technologies- Biomolecular Engineering- Biosensors- Cardiovascular Systems Engineering- Cellular Engineering- Clinical Engineering- Computational Biology- Drug Delivery Technologies- Modeling Methodologies- Nanomaterials and Nanotechnology in Biomedicine- Respiratory Systems Engineering- Robotics in Medicine- Systems and Synthetic Biology- Systems Biology- Telemedicine/Smartphone Applications in Medicine- Therapeutic Systems, Devices and Technologies- Tissue Engineering
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信